Search - tctmd.com

Displaying 281 - 300 of 366

Sort: Relevancy | Date

News Industry News

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

November 10, 2011

News Industry News

Polymer-free drug eluting stents result in lower in-stent late loss

November 10, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Industry News

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

November 10, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures

November 10, 2011

News Industry News

Clinical trial establishes non-inferiority of drug-eluting stent with a bioabsorbable polymer

November 10, 2011

News Industry News

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

November 09, 2011

News Industry News

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

November 09, 2011

News Industry News

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

November 09, 2011

News Industry News

Low CV Event Rate Prompts Closure of Prasugrel Trial

November 09, 2011

News Industry News

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

November 09, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Industry News

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

November 08, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Industry News

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

November 08, 2011

News Industry News

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

November 07, 2011

Advertisement

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

Polymer-free drug eluting stents result in lower in-stent late loss

Paclitaxel-coated balloon angioplasty demonstrates superior results

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures

Clinical trial establishes non-inferiority of drug-eluting stent with a bioabsorbable polymer

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

Low CV Event Rate Prompts Closure of Prasugrel Trial

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content